Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Infectious Diseases

• Publication date

  2013-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jis921PMID 23255566PMCID PMC3685222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase.

  2011cited by this paper
• Filovirus infection of STAT-1 knockout mice.

  2011cited by this paper
• Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

  2010cited by this paper
• Postexposure Treatment of Marburg Virus Infection

  2010cited by this paper
• IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection.

  2010cited by this paper
• Evasion of Interferon Responses by Ebola and Marburg Viruses

  2009cited by this paper
• Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus

  2009cited by this paper
• Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates

  2008cited by this paper
• BMC Bioinformatics BioMed Central

  2008cited by this paper
• The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever

  2007cited by this paper
• Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2

  2007cited by this paper
• Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.

  2007cited by this paper
• Incorporation of gene ontology annotations to enhance microarray data analysis.

  2007cited by this paper
• Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

  2007cited by this paper
• Post-transcriptional control of the interferon system.

  2007cited by this paper
• Filoviruses and Arenaviruses

  2006cited by this paper
• Complex modulation of cell type-specific signaling in response to type I interferons.

  2006cited by this paper
• Marburg hemorrhagic fever associated with multiple genetic lineages of virus.

  2006cited by this paper
• Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.

  2006cited by this paper
• Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.

  2005cited by this paper
• Comparison of non-human primate and human whole blood tissue gene expression profiles.

  2005cited by this paper
• Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions

  2004cited by this paper
• Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.

  2003cited by this paper
• Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.

  2003cited by this paper
• Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

  2003cited by this paper
• Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

  2003influential reference
• Inflammatory responses in Ebola virus‐infected patients

  2002cited by this paper
• Possible contribution of interferon-alpha to febrile seizures in influenza.

  2002cited by this paper
• Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.

  2002cited by this paper
• Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations.

  2002cited by this paper
• Possible contribution of interferon-α to febrile seizures in influenza

  2002cited by this paper
• IFN-β INHIBITS THE ABILITY OF T LYMPHOCYTES TO INDUCE TNF-α AND IL-1β PRODUCTION IN MONOCYTES UPON DIRECT CELL–CELL CONTACT

  2001cited by this paper
• Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.

  2001cited by this paper
• IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.

  2001cited by this paper
• Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in Vitro

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection

  2000cited by this paper
• Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses

  2000cited by this paper
• Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?

  2000cited by this paper
• Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

  1999cited by this paper
• Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.

  1999cited by this paper
• Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.

  1999cited by this paper
• Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection

  1999cited by this paper
• Detection of serum interferon-alpha by dissociation-enhanced lanthanide fluoroimmunoassay. Studies of patients with acute viral and bacterial infections.

  1997cited by this paper
• Detection of serum interferon‐α by dissociation‐enhanced lanthanide fluoroimmunoassay

  1997cited by this paper
• Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses.

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Interferon-Alpha and Tumor Necrosis Factor-Alpha in Serum of Patients in Various Stages of HIV-1 Infection

  1991cited by this paper
• A sensitive radioimmunoassay for circulating alpha-interferon in the plasma of healthy children and patients with measles virus infection.

  1988cited by this paper
• Marburg-virus disease in Kenya.

  1982cited by this paper
• Pathologic and virologic study of fatal Lassa fever in man.

  1982cited by this paper
• Congo-Crimean haemorrhagic fever in Dubai: histopathological studies.

  1981cited by this paper
• Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues.

  1981cited by this paper
• Letter: Percutaneous lung biopsy.

  1976cited by this paper
• Manual of clinical microbiology

  1975cited by this paper
• Manual of Clinical Microbiology

  1970cited by this paper

• Asian elephant interferons alpha and beta and their anti-herpes viral activity

  2025cites this paper
• Antiviral defense against filovirus infections: targets and evasion mechanisms

  2025cites this paper
• Interferons Inhibit Ebola Virus Infection of Human Keratinocytes

  2025cites this paper
• Marburg Virus Disease: Epidemiological Surveillance, Public Health Preparedness, and Infection Control Strategies within Healthcare Systems

  2025cites this paper
• Emerging Strategies and Progress in the Medical Management of Marburg Virus Disease

  2025cites this paper
• Marburg Virus: A comprehensive examination of a critical pathogen

  2024cites this paper
• An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses

  2024cites this paper
• Post-exposure intranasal IFNα suppresses replication and neuroinvasion of Venezuelan Equine Encephalitis virus within olfactory sensory neurons

  2024cites this paper
• Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMapp.

  2024cites this paper
• Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication

  2023cites this paper
• Beyond survival: unraveling the dynamics of Ebola virus resurgence in Sub-Saharan Africa and the remarkable journey of survivors

  2023cites this paper
• Computed Tomography Imaging for Monitoring of Marburg Virus Disease: a Nonhuman Primate Proof-Of-Concept Study

  2023cites this paper
• Interferon therapy and its association with depressive disorders – A review

  2023cites this paper
• Pathogenicity and virulence of Marburg virus

  2022cites this paper
• Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon

  2021cites this paper
• The discovery and development of novel treatment strategies for filoviruses

  2021cites this paper
• Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application

  2021cites this paper
• Development of a New Reverse Genetics System for Ebola Virus

  2021cites this paper
• Use of immunostimulants in the successful treatment of a clinical EEHV1A infection in an Asian elephant (Elephas maximus)

  2020cites this paper
• A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of Type I Interferon.

  2020cites this paper
• Combating biothreat pathogens: ongoing efforts for countermeasure development and unique challenges

  2020cites this paper
• Marburg virus disease: A summary for clinicians

  2020cites this paper
• Determinants of patient survival following acute Ebola virus infection

  2019cites this paper
• Global virus outbreaks: Interferons as 1st responders

  2019cites this paper
• Developing Therapeutics for Ebola Virus Disease: A Multifaceted Approach

  2019cites this paper
• Epidemiological Trends and Current Challenges in Ebola: Pathogen Biology, Drug Targets, and Therapeutic Strategies

  2019cites this paper
• Role of Type I Interferons on Filovirus Pathogenesis

  2019cites this paper
• Ebola Virus: Pathogenesis and Countermeasure Development.

  2019cites this paper
• Ebola virus disease: An emerging and re-emerging viral threat.

  2019cites this paper
• Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection

  2019cites this paper
• Ebola virus disease: Recent advancs in diagnostics and therapeutics

  2019cites this paper
• Review on the Epidemiology and Public Health Importance of Marburg Hemorrhagic Fever in Africa

  2019cites this paper
• How myeloid cells contribute to the pathogenesis of prominent emerging zoonotic diseases.

  2018cites this paper
• Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40

  2018cites this paper
• Chapter 27 MEDICAL COUNTERMEASURES

  2018cites this paper
• Post-exposure treatments for Ebola and Marburg virus infections

  2018cites this paper
• Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

  2018cites this paper
• Immune barriers of Ebola virus infection.

  2018cites this paper
• Pharmacoinformatics-based identification of chemically active molecules against Ebola virus

  2018cites this paper
• Ebola Immunity: Gaining a Winning Position in Lightning Chess

  2018cites this paper
• Kinase Inhibitors and Nucleoside Analogues as Novel Therapies to Inhibit HIV-1 or ZEBOV Replication

  2017cites this paper
• Host Transcriptional Response to Ebola Virus Infection

  2017cites this paper
• Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye

  2017cites this paper
• Ebola Virus Infection: a review on the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials

  2017cites this paper
• Interferon-&bgr; and Interferon-&ggr; Are Weak Inhibitors of Ebola Virus in Cell-Based Assays

  2017cites this paper
• Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles

  2017cites this paper
• Discovering Drugs for the Treatment of Ebola Virus

  2017cites this paper
• Implications of Toll-like receptors in Ebola infection

  2017cites this paper
• Ebola Virus Disease in Humans: Pathophysiology and Immunity

  2017cites this paper
• Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus

  2017cites this paper
• Novel Stable Ebola Virus Minigenome Replicon Reveals Remarkable Stability of the Viral Genome

  2017cites this paper
• Therapeutics Against Filovirus Infection.

  2017cites this paper
• Will There Be a Cure for Ebola?

  2017cites this paper
• Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review

  2017cites this paper
• Clinical Evaluation of Ebola Virus Disease Therapeutics.

  2017influential citation
• Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial

  2017cites this paper
• Application of a quantitative entry assessment model to compare the relative risk of incursion of zoonotic bat-borne viruses into European Union Member States

  2017cites this paper
• Le virus Ebola : impact de l’épidémie de 2014-2016 sur la recherche

  2017cites this paper
• Therapeutic Strategies against Ebola Virus Infection

  2016influential citation
• Maladie à virus Ebola : actualités thérapeutiques

  2016cites this paper
• Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

  2016cites this paper
• A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus

  2016cites this paper
• Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials

  2016cites this paper
• Ebola vaccine, therapeutics, and diagnostics.

  2016cites this paper
• Antiviral therapeutics for the treatment of Ebola virus infection.

  2016cites this paper
• Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

  2016cites this paper
• Interferon Beta: From Molecular Level to Therapeutic Effects.

  2016cites this paper
• Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates

  2016cites this paper
• A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice

  2016cites this paper
• Prevention of Ebola

  2015cites this paper
• Promising Therapeutics against Ebola Virus Disease.

  2015cites this paper
• Vesicular stomatitis virus (VSV) as a paradigm for predicting antiviral activity against Ebola virus (EBOV)

  2015cites this paper
• Pre-symptomatic diagnosis and treatment of filovirus diseases

  2015cites this paper
• Ebola virus: entry, pathogenesis and identification of host antiviral activities

  2015cites this paper
• State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus.

  2015cites this paper
• Болезнь, вызываемая вирусом ЭБола: от теории к пр актике

  2015cites this paper
• Therapeutics for postexposure treatment of Ebola virus infection.

  2015cites this paper
• Backs against the Wall: Novel and Existing Strategies Used during the 2014-2015 Ebola Virus Outbreak

  2015cites this paper
• Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis

  2015cites this paper
• Small molecule inhibitors of ebola virus infection.

  2015cites this paper
• Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material

  2015cites this paper
• The Role of Cytokines and Chemokines in Filovirus Infection

  2015cites this paper
• Interferon-γ Inhibits Ebola Virus Infection

  2015cites this paper
• Filoviruses: One of These Things is (not) Like the Other

  2015cites this paper
• Non-specific anti-viral approach towards Ebola virus infection: a comment on “Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis”

  2015cites this paper
• A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.

  2015cites this paper
• Ebola: history, treatment, and lessons from a new emerging pathogen.

  2015cites this paper
• Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

  2015cites this paper
• Development of therapeutics for treatment of Ebola virus infection.

  2015cites this paper
• Ebola Virus Infection: Overview and Update on Prevention and Treatment

  2015cites this paper
• Translational Research in Acute Lung Injury and Pulmonary Fibrosis Ebola : history , treatment , and lessons from a new emerging pathogen

  2015cites this paper
• Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection

  2015cites this paper
• Ebola virus disease in nonendemic countries

  2015cites this paper
• Ebola Fever and Advances in the Antiviral Therapies

  2015cites this paper
• Cytokines and viral hemorrhagic fever: potential for therapeutic intervention

  2015cites this paper
• Transcriptional Profiling of the Immune Response to Marburg Virus Infection

  2015cites this paper
• Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus

  2014influential citation
• Ebola virus (EBOV) infection: Therapeutic strategies

  2014cites this paper
• Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.

  2014cites this paper
• Ebola Outbreak Response; Experience and Development of Screening Tools for Viral Haemorrhagic Fever (VHF) in a HIV Center of Excellence Near to VHF Epicentres

  2014cites this paper